MILESTONE SCIENTIFIC INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Market Information
Since June 1, 2015, our common stock has been listed on the NYSE American under the symbol “MLSS”. The following table sets forth the high and low sales prices of Milestone’s common stock for the periods presented.
| 2023 | High | Low | 2022 | High | Low |
|---|---|---|---|---|---|
| First Quarter | $1.00 | $0.46 | First Quarter | $2.20 | $1.13 |
| Second Quarter | $1.22 | $0.72 | Second Quarter | $1.60 | $0.75 |
| Third Quarter | $1.35 | $0.81 | Third Quarter | $1.27 | $0.71 |
| Fourth Quarter | $1.00 | $0.56 | Fourth Quarter | $0.87 | $0.45 |
Holders
As of March 29, 2024, we had approximately 97 stockholders of record of our common stock. We believe that, in addition to the record owners, we have approximately 3,318 beneficial ownersof our common stock.
Dividends
The holders of common stock are entitled to receive such dividends as may be declared by Milestone Scientific’s Board of Directors. Milestone Scientific has not paid and does not expect to declare or pay any dividends in the foreseeable future.
Sales of Unregistered Securities
Not applicable.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.